You searched for "MIGS"
Scottish Glaucoma Symposium 2022 (Scottish Glaucoma Club)
The Scottish Glaucoma club first started its June symposium in 1999 and since 2004 it has been an annual event. This is a day meeting, held at the Royal College of Surgeons Edinburgh and covers a variety of aspects of...Welcome Nick Smith to Sight Sciences International Team
Sight Sciences is happy to welcome Nick Smith to its International Team. Nick joins as Senior Product Manager and will head up international marketing for the company’s Surgical Glaucoma division.
MicroRNA inhibits corneal neovascularisation
MicroRNAs (miR) are small non-coding RNA that target mRNA for destruction. MiR target about 30% of the protein coding genes and fine tune their expression. MiR have been shown to be involved in several cellular processes including cell cycle, tissue...Sharing best practice and landmark evidence in glaucoma care
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...Cutting-edge practice in glaucoma care: what, how and why?
More effective treatments and drug delivery modalities, implantable minimally invasive glaucoma surgical (MIGS) devices, as well as accelerating clinical research programmes, will transform the surgical and clinical management of glaucoma in the near future. There is also an ever-greater emphasis...iStent inject®, at the time of cataract surgery show improved QOL (QUALITY OF LIFE) vs cataract alone
In an analysis of Patient Reported Outcome (PRO) data (VFQ-25 and OSDI questionnaires) from the Randomized Control Pivotal Trial (RCT) of iStent inject ®, subjects undergoing iStent inject ® plus cataract surgery reported greater vision-related quality of life improvement than cataract surgery alone.
MISS vs. fornix approach
The objectives of this study were to compare minimally invasive strabismus surgery (MISS) with the fornix approach in paediatric horizontal strabismus surgery (<12 years) and to evaluate early postoperative inflammation, visual acuity and operating time after a four-year training period...The science of glaucoma management: highlights of the 2020 Moorfields International Glaucoma Symposium
Held earlier this year, the 12th annual Moorfields International Glaucoma Symposium provided a forum for advanced clinical and scientific exchange in glaucoma management. The authors describe the key presentation themes and debates, highlighting specific topics of interest to glaucoma specialists....Tough gig
‘The times they are a-changin’. The words of this Dylan classic resonate down the decades, and in the light of recent events, speak eloquently to life in 2022. It feels like a lifetime of change has passed since the Eye...Sight Sciences OMNI® Masterclass, Birmingham
Saturday 9 July saw Sight Sciences hold their first UK Masterclass for the OMNI Surgical System. Delegates and faculty gathered at Aston University, Birmingham for the event, which was a mix of lectures, discussion and a guided dry-lab.A closer look at the new wave of glaucoma surgery – radical or old school?
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...
